AstraZeneca PLC (AZN)
$155.82-1.59%Close
SELLRECOVERY · day 46
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $120.8B
- Beta
- 0.21
- Div yield
- 2.07%
- P/E (TTM)
- 23.51
- Short % float
- 0.34%
- Days to cover
- 1.0
- SI change
- +25.4%
- 1W
- -1.76%
- 1M
- -4.86%
- vs SPY 1W
- -1.62%
- vs SPY 1M
- -7.37%
Industry peers
FMP comparable companies · ranked by market cap
- LLYBUYEli Lilly and Company$1.1TRECOVERYQ 21$1169.93-1.36%
- JNJSELLJohnson & Johnson$618.1BBEARQ 22$256.48-5.73%
- ABBVBUYAbbVie Inc.$481.3BBULLQ 29$272.42-2.40%
- MRKSELLMerck & Co., Inc.$351.7BBEARQ 11$142.40-2.39%
- RHHBYRoche Holding AG$340.1B$53.36
- NVSBUYNovartis AG$272.0BRECOVERYQ 20$143.11-0.99%
- AMGNBUYAmgen Inc.$219.9BRECOVERYQ 22$407.44-1.13%
- NVOSELLNovo Nordisk A/S$169.5BRECOVERYQ 20$38.18-1.35%
- PFESELLPfizer Inc.$158.6BBULLQ 13$27.82-0.11%
- BMYSELLBristol-Myers Squibb Company$121.7BBEARQ 10$59.58-1.58%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on AZN?
- LOPJLB’s latest quantitative signal on AstraZeneca PLC (AZN) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is AZN in?
- AstraZeneca PLC (AZN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does AstraZeneca PLC (AZN) do?
- AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, …